Literature DB >> 26086752

Adoptive Engineered T-Cell Trials to Achieve Cancer Killing (ATTACK).

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26086752     DOI： 10.1089/humc.2015.2521

Source DB:  PubMed          Journal:  Hum Gene Ther Clin Dev        ISSN： 2324-8637            Impact factor:   5.032


× No keyword cloud information.
  1 in total

Review 1.  Opportunities for vaccine research in Europe.

Authors:  David Gancberg; Arnd Hoeveler; Alessandra Martini; Ruxandra Draghia-Akli
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.